Feys, Simon http://orcid.org/0000-0002-7516-9471
Heylen, Jannes
Carvalho, Agostinho
Van Weyenbergh, Johan
Wauters, Joost
Gonçalves, Samuel M.
Cunha, Cristina
Debaveye, Yves
Hermans, Greet
Humblet-Baron, Stephanie
Jacobs, Cato
Lambrechts, Diether
Mombaerts, Peter
Lagrou, Katrien
Meersseman, Philippe
Menezes, Soraya Maria
Peetermans, Marijke
Rocha-Pereira, Joana
Seldeslachts, Laura
Starick, Marick Rodrigues
Thevissen, Karin
Vandenbriele, Christophe
Vanderbeke, Lore
Vande Velde, Greetje
Van De Veerdonk, Frank L.
Wilmer, Alexander
,
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (G053121N, G0A0621N)
Horizon 2020 (847507 HDM-FUN)
Article History
Accepted: 8 December 2022
First Online: 2 January 2023
Declarations
:
: SF received travel grants from Pfizer. JW received investigator-initiated grants from Pfizer, Gilead and MSD and speakers’ and travel fees from Pfizer, Gilead and MSD, and declares participation in advisory boards of Pfizer and Gilead, and receipt of study drugs from MSD. CV received speaker fees from Pfizer. KL received consultancy fees from Gilead, speaker fees from FUJIFILM Wako, Pfizer and Gilead and a service fee from TECOmedical. YD reports speakers’ and travel fees from Pfizer and participation in advisory boards of Pfizer. The other authors declare no conflict of interest.